The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis

被引：0

作者：

Mazloomzadeh, Saeideh ^{[1
]}

Khazaghi, Zahra Rashidi ^{[1
]}

Mousavinasab, Nouraddin ^{[1
]}

机构：

[1] Zanjan Univ Med Sci, Zanjan Metab Dis Res Ctr, Zanjan, Iran

来源：

IRANIAN JOURNAL OF PUBLIC HEALTH | 2018年 / 47卷 / 04期

关键词：

Metabolic syndrome; Prevalence; Systematic review; Meta-analysis; RISK-FACTORS; NONCOMMUNICABLE DISEASES; INSULIN-RESISTANCE; POPULATION; DEFINITION; OBESITY; WOMEN; EAST;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Background: Metabolic syndrome (MS) is a collection of metabolic disorders which leads to early cardiovascular disease and diabetes type II. Regarding the wide range of its prevalence in Iran, this systematic review and meta-analysis determined the overall prevalence of the metabolic syndrome in Iran. Methods: In this systematic review and meta-analysis, the Medline, ISI, IranMedex, and SID were searched using "metabolic syndrome", "syndrome X", "prevalence", and "Iran" keywords from 2002 to 2012. A total of 223 articles were found in which 14 studies were considered for meta-analysis. Data were analyzed using fixed and random model and meta-regression in STATA. Results: The prevalence of MS for those who were 20 yr and older was 23. 8% (95% CI: 18. 99-28. 67) and in under 20 was 10. 98% (95% CI: 7. 75-14. 2). Metabolic syndrome was more frequent in women (25. 5%) than in men (17. 16%) and was increased with increasing age. The most frequent component of metabolic syndrome was low HDL cholesterol (59. 7%) followed by hypertriglyceridemia (39. 5%). Conclusion: Regarding a high prevalence of metabolic syndrome and some of its components such as low HDL and high triglyceride in our country, implementation of programs for metabolic syndrome prevention is necessary.

引用

页码：473 / 480

页数：8

共 38 条

[1] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].

Alberti, KGMM ;

Zimmet, P ;

Shaw, J .

DIABETIC MEDICINE, 2006, 23 (05) :469-480

[2] Prevalence of metabolic syndrome in the Spanish working population:: MESYAS registry [J].

Alegría, E ;

Cordero, A ;

Laclaustra, M ;

Grima, A ;

León, M ;

Casasnovas, JA ;

Luengo, E ;

del Río, A ;

Ferreira, I .

REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (07) :797-806

[3]

Alzahrani AM, 2012, The British Journal of Diabetes & Vascular Disease, P78, DOI [10.1177/1474651412441953, DOI 10.1177/1474651412441953]

[4]

Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198

[5]

[Anonymous], 2009, IRAN J ENDOCRINOL ME

[6] Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study [J].

Azizi, F ;

Salehi, P ;

Etemadi, A ;

Zahedi-Asl, S .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) :29-37

[7]

Balkau B, 2002, DIABETES METAB, V28, P364

[8]

Barahimi H, 2008, IRAN J DIABET METAB, V8, P177

[9] The metabolic syndrome in Australia: prevalence using four definitions [J].

Cameron, Adrian J. ;

Magliano, Dianna J. ;

Zimmet, Paul Z. ;

Welborn, Tim ;

Shaw, Jonathan E. .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (03) :471-478

[10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

← 1 2 3 4 →